New Britain, PA, United States of America

Richard Colonno

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Colonno. Retrieved from https://idiyas.com/inventor/richard-colonno-eu5tkkj5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Richard Colonno

Introduction

Richard Colonno is a notable inventor residing in New Britain Township, Bucks County, Pennsylvania. He has made significant contributions to the field of biochemistry, particularly in the pursuit of antiviral therapies. With a focus on innovative peptide sequences, Colonno's work has the potential to impact how we combat viral infections, specifically those caused by the herpes simplex virus.

Latest Patents

Colonno holds a patent for an inhibitor of ribonucleotide reductase, a crucial enzyme involved in viral replication. His patented pentapeptide sequence, composed of Val Val Asn Asp Leu, has been identified as the shortest effective peptide to inhibit this enzyme in vitro. This breakthrough discovery paves the way for developing more potent inhibitors through longer peptide sequences, expanding the toolbox available in antiviral drug creation.

Career Highlights

Richard Colonno is associated with Merck & Company, Inc., a leading global biopharmaceutical company that focuses on discovering, developing, and providing innovative health solutions. His work at Merck has facilitated advancements in therapeutic interventions against viral diseases, showcasing his dedication to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Colonno has collaborated with several distinguished coworkers, including Victor M. Garsky and John Hannah. These collaborations have furthered the research and development efforts in their respective fields, highlighting the importance of teamwork in scientific innovation and demonstrating a collective pursuit of knowledge that enhances drug efficacy and safety.

Conclusion

In conclusion, Richard Colonno's contributions to the scientific community through his patent in antiviral research exemplify the importance of innovation in the fight against viral infections. His work has the potential to change treatment paradigms and improve patient outcomes, solidifying his role as an impactful inventor in modern medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…